Medigene AG buy Amped
Start price
29.11.21
/
0%
€3.03
Target price
29.11.22
-
Performance (%)
-21.12%
End price
30.11.22
€2.39
Summary
This prediction ended on 30.11.22 with a price of €2.39. The prediction for Medigene AG disappointed with a performance of -21.12%. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Medigene AG | -18.622% | -18.622% | -10.141% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% |
According to Amped what are the pros and cons of Medigene AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Standard Investments for future growth
Capable Management
Good culture
Innovative
Growths faster than the competition
Stable Large shareholder and/or long term investor
Known brand
Very Future proof/growth oriented business model
Cons
Dependend from some customers or products
Sustainability is little important
Higher risks for its business
Significant cyclical dependencies
Below average Marketposition
Comments by Amped for this prediction
In the thread Medigene AG diskutieren
Buy Medigene AG
In the thread Trading Medigene AG
Die von Amped gewählte maximale Laufzeit wurde überschritten